Видео ютуба по тегу Cdmo India

Influx Healthtech’s 3× Capacity Expansion by FY27 —CDMO- Inside the ₹500 Cr Growth Plan
Influx Healthtech’s 3× Capacity Expansion by FY27 —CDMO- Inside the ₹500 Cr Growth Plan
Sandeep Tandon Bullish On India 2026 | SMIDs, Old Economy In Focus | Outlook 2026 | ET Now
Sandeep Tandon Bullish On India 2026 | SMIDs, Old Economy In Focus | Outlook 2026 | ET Now
2026 Market Outlook: Vikas Khemani Decodes Where India’s Alpha Lies | Indian Equities Explained
2026 Market Outlook: Vikas Khemani Decodes Where India’s Alpha Lies | Indian Equities Explained
Eurofins CDMO India - Process Development and Manufacturing Services
Eurofins CDMO India - Process Development and Manufacturing Services
State of Indian Pharma Industry in December 2025: The Great Stratification
State of Indian Pharma Industry in December 2025: The Great Stratification
India Is Turning Out To Be A Significant Market For GLP-1: Onesource Specialty | CNBC TV18
India Is Turning Out To Be A Significant Market For GLP-1: Onesource Specialty | CNBC TV18
Innova Captab Q2 FY26 Concall: Pharma CDMO Growth, Margins & Outlook
Innova Captab Q2 FY26 Concall: Pharma CDMO Growth, Margins & Outlook
Компания Piramal Pharma о возможностях контрактного производства и разработки лекарственных препа...
Компания Piramal Pharma о возможностях контрактного производства и разработки лекарственных препа...
HOW INDIA BECOME A GLOBAL HUB FOR CDMO SERVICE
HOW INDIA BECOME A GLOBAL HUB FOR CDMO SERVICE
Как начать бизнес по организации контрактных исследовательских проектов (CRO) в Индии | Руководст...
Как начать бизнес по организации контрактных исследовательских проектов (CRO) в Индии | Руководст...
Мегатренд в индийской полупроводниковой и контрактной контрактной индустрии: акции с высоким поте...
Мегатренд в индийской полупроводниковой и контрактной контрактной индустрии: акции с высоким поте...
How US Biosecure Act Will Force A 'Structural Reset' For Indian Pharma | NDTV Profit
How US Biosecure Act Will Force A 'Structural Reset' For Indian Pharma | NDTV Profit
US Biosecure Act To Impact Indian Pharma Companies, CDMOs' New Edge Over Chinese Competitors?
US Biosecure Act To Impact Indian Pharma Companies, CDMOs' New Edge Over Chinese Competitors?
Индийская индустрия контрактного производства и разработки лекарственных препаратов (CDMO) значит...
Индийская индустрия контрактного производства и разработки лекарственных препаратов (CDMO) значит...
Won't See An Earnings Upside For CDMO Cos In The Next 1 Year: Macquarie Capital | CNBC TV18
Won't See An Earnings Upside For CDMO Cos In The Next 1 Year: Macquarie Capital | CNBC TV18
Why Are Big Pharma Companies Choosing India?
Why Are Big Pharma Companies Choosing India?
The next Mega sector opportunity for India Inc?
The next Mega sector opportunity for India Inc?
Sai Life Sciences: The CDMO Powerhouse Everyone Is Ignoring !!
Sai Life Sciences: The CDMO Powerhouse Everyone Is Ignoring !!
Indian Pharma CDMO 101- Neuland, Syngene, Suven Pharma || Part 01
Indian Pharma CDMO 101- Neuland, Syngene, Suven Pharma || Part 01
India Pharma Outlook: Tariffs, CDMO Boom & Hospital Growth | JM Financial’s View On China & US
India Pharma Outlook: Tariffs, CDMO Boom & Hospital Growth | JM Financial’s View On China & US
Aarti Pharmalabs: India’s Next Pharma Giant?
Aarti Pharmalabs: India’s Next Pharma Giant?
Satyam vs India: The Scam That Changed the Markets FULL STORY | The Valuation School
Satyam vs India: The Scam That Changed the Markets FULL STORY | The Valuation School
India’s CDMO Surge – Reshaping the Global Pharma Supply Chain
India’s CDMO Surge – Reshaping the Global Pharma Supply Chain
Laurus Labs Q2 FY26 Concall: Pharma & CDMO Segments Drive Revenue Recovery
Laurus Labs Q2 FY26 Concall: Pharma & CDMO Segments Drive Revenue Recovery
Lauras Labs Q2 Results | 850 %PAT growth YOY| Future guidance covered |CDMO growth | ~5000 cr Capex
Lauras Labs Q2 Results | 850 %PAT growth YOY| Future guidance covered |CDMO growth | ~5000 cr Capex